Targeted-release budesonide therapy for IgA nephropathy

Bengt Fellström and colleagues (May 27, p 2117)1 report that the addition of a targeted-release formulation of budesonide (TRF-budesonide) to an optimised renin-angiotensin system (RAS) blockade reduced proteinuria in patients with IgA nephropathy. However, whether patients with proteinuria of 0·5-1...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet (British edition) 2017-12, Vol.390 (10113), p.2625-2625
Hauptverfasser:	Tsuda, Kenji, Tanimoto, Tetsuya, Mori, Jinichi, Kosugi, Kazuhiro, Komatsu, Tsunehiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Drug therapy Immunoglobulins Kidney diseases Steroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!